• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Fujian Medical University

Headquarters: Fuzhou, China
Year Founded: 1937
Status: N/A

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Dec 16, 2024
Distillery Therapeutics

Splice-altering ASO for primary familial brain calcification

BioCentury | Oct 2, 2024
Distillery Therapeutics

NUAK1 for gastric cancer chemoresistance

BioCentury | Apr 20, 2023
Discovery & Translation

CRISPR guide RNAs with guardrails, bacterial sensors for pathogen detection and more

BioCentury’s roundup of translational news
BioCentury | Nov 23, 2022
Data Byte

Translational spotlight on East-West innovation 

Collaborations between investigators at Asian and Western universities in BioCentury’s Distillery present licensing and partnering opportunities
BioCentury | Apr 8, 2021
Distillery Therapeutics

PON-2 identified as B cell-ALL target

DISEASE CATEGORY: Cancer
INDICATION: Acute lymphoblastic leukemia (ALL) Inhibiting PON2, a lactonase, could treat B cell ALL (B-ALL). Levels of PON2 mRNA were higher in Philadelphia
Items per page:
1 - 6 of 6